News

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...
The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.
Louisville, Ky.-based Humana contracted with Madison, Wis.-based Exact Sciences Corp. to cover Cologuard — a colon cancer test — as an in-network service for its members. Effective Jan. 1 ...
Madison, Wis.-based Exact Sciences Corp. agreed to a contract with Louisville, Ky.-based Humana to cover its Cologuard colon cancer screening test as an in-network service.
Cologuard Plus is a more sensitive version of the original Cologuard that was first approved in 2014. The test is for people 45 and older who are at average risk of colorectal cancer, meaning ...
5. Cologuard received FDA approval in August 2014 and published results from the clinical trial with 10,000 patients in the New England Journal of Medicine in March 2014. Last year, the U.S.
A decade ago, Exact Sciences launched Cologuard, impacting the fight against colorectal cancer. Its growth of 7000% is in part due to a focus on consumerization.
Ten years after first collecting an FDA approval, it’s time for version number two. Exact Sciences has received an agency green light for Cologuard Plus, the next generation of its mainstay, at ...
Cologuard is a non-invasive test for colon cancer that you can perform in the comfort of your own home. It checks for evidence of cancer in a small sample of stool (poop) that you mail to a lab.
Colorectal Cancer Awareness Month is observed every year during March and aims to promote screening and early detection, raise awareness, and offer support to those battling the disease. Since March ...